Endo Health Solutions (NAS: ENDP) is expected to report Q2 earnings on Aug. 6. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Endo Health Solutions's revenues will compress -8.1% and EPS will wither -9.4%.
The average estimate for revenue is $721.6 million. On the bottom line, the average EPS estimate is $1.15.
Last quarter, Endo Health Solutions notched revenue of $708.5 million. GAAP reported sales were 2.6% higher than the prior-year quarter's $690.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
Last quarter, non-GAAP EPS came in at $1.09. GAAP EPS were $0.14 for Q1 versus -$0.75 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
For the preceding quarter, gross margin was 59.6%, 350 basis points worse than the prior-year quarter. Operating margin was 21.7%, 830 basis points better than the prior-year quarter. Net margin was 2.2%, much better than the prior-year quarter.
The full year's average estimate for revenue is $2.75 billion. The average EPS estimate is $4.33.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 420 members out of 444 rating the stock outperform, and 24 members rating it underperform. Among 143 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 136 give Endo Health Solutions a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Endo Health Solutions is hold, with an average price target of $32.53.
- Add Endo Health Solutions to My Watchlist.
The article Endo Health Solutions Earnings Are on Deck originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.